These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 9579301

  • 1. Increased ocular pressure in two patients with narrow angle glaucoma treated with venlafaxine.
    Aragona M, Inghilleri M.
    Clin Neuropharmacol; 1998; 21(2):130-1. PubMed ID: 9579301
    [Abstract] [Full Text] [Related]

  • 2. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R, Perkins TW, Gangnon R, Kaufman PL, Heatley GA.
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [Abstract] [Full Text] [Related]

  • 3. The uniocular drug trial and second-eye response to glaucoma medications.
    Realini T, Fechtner RD, Atreides SP, Gollance S.
    Ophthalmology; 2004 Mar; 111(3):421-6. PubMed ID: 15019313
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 5. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
    Aung T, Chan YH, Chew PT, EXACT Study Group.
    Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of pneumatic traheculoplasty (PNT) in patients with open angle glaucoma and ocular hypertension--a preliminary report].
    Wierzbowska J, Stankiewicz A, Romańska Ł.
    Klin Oczna; 2008 Feb; 110(7-9):287-91. PubMed ID: 19112863
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [Abstract] [Full Text] [Related]

  • 8. Dose-related increase of intraocular pressure caused by venlafaxine use: case report.
    Della Mônica M, D'Elia G, de Andrade AG, Alves TC.
    J Clin Psychopharmacol; 2008 Apr; 28(2):252-4. PubMed ID: 18344748
    [No Abstract] [Full Text] [Related]

  • 9. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.
    Chew PT, Aung T, Aquino MV, Rojanapongpun P, EXACT Study Group.
    Ophthalmology; 2004 Mar; 111(3):427-34. PubMed ID: 15019314
    [Abstract] [Full Text] [Related]

  • 10. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [Abstract] [Full Text] [Related]

  • 11. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H, Habot-Wilner Z, Burla N, Melamed S, Goldenfeld M, Bar-Sela SM, Sachs D.
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [Abstract] [Full Text] [Related]

  • 12. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
    Lam DS, Leung DY, Tham CC, Li FC, Kwong YY, Chiu TY, Fan DS.
    Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
    Alexandrino-Silva C, Nadalini Mauá FH, de Andrade AG, de Toledo Ferraz Alves TC.
    J Psychopharmacol; 2008 Mar; 22(2):214-6. PubMed ID: 18208934
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [Abstract] [Full Text] [Related]

  • 16. Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication.
    Holló G, Vargha P, Kóthy P.
    Curr Med Res Opin; 2005 Dec; 21(12):1943-8. PubMed ID: 16368044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA, Nau CB, McLaren JW, Johnson DH.
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I, Harris A, Kagemann L, Siesky B, McCranor L.
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.